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Peroxisome proliferator-activated receptor (PPAR) b}d is ubiqui-
tously expressed, but the level of expression differs markedly
between different cell types. In order to determine the mol-
ecular mechanisms governing PPARb}d gene expression, we
have isolated and characterized the mouse gene encoding
PPARb}d. The gene spans approx. 41 kb and comprises 11 exons
of which the six exons located in the 3«-end of the gene are
included in all transcripts. Primer-extension and 5«-rapid ampli-
fication of cDNA ends experiments revealed the presence of
multiple transcription start points and splice variants, originating
from the use of at least four different promoters. One of these
INTRODUCTION
The peroxisome proliferator-activated receptor (PPAR) sub-
family of the nuclear hormone receptors comprises three dis-
tinct subtypes found in vertebrate species, PPARa, PPARb}d
[also named nuclear hormone receptor 1 (NUC) or fatty acid-
activated receptor (FAAR)] and PPARc. They function as
ligand-activated receptors and regulators of transcription re-
sponding to a wide range of ligands, including fatty acids,
eicosanoids, fibrates and thiazolidinediones.
Whereas the importance of PPARa and PPARc in the control
of lipid homeostasis and cellular growth and differentiation
have been well established, the role of PPARb}d remained elus-
ive until recently, where a number of studies have implicated
PPARb}d in various processes. Thus PPARb}d has been pro-
posed to be involved in the differentiation of oligodendrocytes
[1], epithelial cells [2,3], keratinocytes [4] and adipocytes [5–7].
PPARb}d seems also to play an important role in lipid metab-
olism in the brain [8], in the regulation of uncoupling protein 3
levels in myotubes [9], in cholesterol homeostasis [10,11] and in
bone metabolism [12]. Moreover, recent data suggest important
roles for PPARb}d in skin wound healing [13], and in embryo
implantation and decidualization [14]. PPARb}d-null mice also
have altered myelination in the central nervous system, reduced
adipose stores and changes in the response to PMA-induced
inflammation and hyperproliferation of the epidermis [8,15].
Finally, a role in the initiation of colon cancer has been suggested
[16–18], although recent data indicate that PPARb}d is dis-
pensable for polyp formation in APC(min) mice [19].
The genomic structures of the genes encoding mouse PPARa
and PPARc have been described [20,21], and here we present a
detailed analysis of the genomic structure of the gene encoding
mouse PPARb}d. The mouse PPARb}d gene contains a total
Abbreviations used: DMEM, Dulbecco’s modified Eagle’s medium; IRES, internal ribosome entry site ; M-MLV, Moloney-murine-leukaemia virus ;
PPAR, peroxisome proliferator-activated receptor ; RACE, rapid amplification of cDNA ends; UTR, untranslated region.
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transcription start points was found to be used predominantly in
all tissues examined. Initiation from this major transcription
start point gives rise to a transcript with a 548 nt 5«-untranslated
leader containing eight upstream AUG codons. We show that
the presence of the 548 nt leader resulted in a low translational
efficiency of the corresponding PPARb}d mRNA and propose,
based on structural features of the 5«-untranslated region, that
translational initiation may be mediated via an internal ribosome
entry site-dependent mechanism.
Key words: expression, nuclear hormone receptor, translation.
of 11 exons; the six exons in the 3«-end encode the PPARb}d
protein. The organization of the coding exons of PPARb}d cor-
responds to that of the genes encoding PPARa and PPARc.
Compared with the human PPARb}d gene [22] we noticed
several differences in the 5«-region of the mouse gene, where the
number and organization of exons appear to differ in the two
species.Alternative promoter usage gives rise to four differentially
spliced versions of PPARb}d mRNAs containing one or two
non-coding 5«-exons, and we present evidence suggesting that
PPARb}d expression is regulated at the post-transcriptional
level. The transcript found to be most abundantly expressed in
the tissues examined has features in common with mRNAs
depending on internal ribosome entry site (IRES)-mediated
translational initiation and post-transcriptional regulation, and
we propose that the initiation of translation of this prominent
PPARd transcript may be accomplished via an IRES-dependent
mechanism.
EXPERIMENTAL
Genomic cloning and Southern analysis
A mouse genomic library in k FIXTM II was screened using
$#P-labelled PPARb}d mRNA [23,24]. Positive clones were
isolated and purified by three successive rounds of screening.
Three genomic P1 clones were obtained from Genome Systems
(St. Louis, MO, U.S.A.) after PCR screening with the primers
5«-CCTGCAGGCCTGGTCATAGC-3« and 5«-GGACAGCT-
GCGTCCTGAG-3«. The clones were further screened by PCR
with the primer sets 5«-GGATTCTGCGGAGCGTGCG-3«}
5«-CTGTCAGTGAGCAGGAGCCTC-3« and 5«-GGCGAC-
CTGGGGATTAATG-3«} 5«-CTGTCCCGGCCGCCTCTC-3«.
One of these clones, plate 91, was used for the preparation of
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genomic subclones harbouring exons 1B, 1C and 2 by partial
cutting with Sau3AI and cloning of the fragments into the
BamHI site of pBluescript KS› (Stratagene). Subclones har-
bouring these exons were found by colony hybridization using
the oligonucleotide probes 5«-CTGTCCCGGCCGCCTCTC-3«
and 5«-CTGTCAGTGAGCAGGAGCCTC-3«, respectively. The
P1 clone was used as a template for obtaining genomic clones
containing exon 1A and 1D by long-range PCR using the
BioExact enzyme mixture (Bioline). Here the primer pairs
5«-GGCCGTCGACATTTAGGTGACAC-3« } 5«-AGGGCTC-
AGGAGCGGCTTC-3«and 5«-GGGGCTGCTTGCTAAATA-
GG-3«}5«-CAGTCCTGTCTCCAGATCTG-3« were employed
for the PCR amplifying exons 1A and 1D, respectively. The
resultant fragments were cloned into pCRII TOPO. Genomic
subclones covering exons 3–8 were generated by cutting the k
clones with XbaI and cloning of the resulting fragments into the
XbaI site of pBluescript KS›.
Sequencing was performed on an A.L.F. (Pharmacia) or a
CEQ2000 (Beckman-Coulter) sequencer except a short GC-rich
stretch in exon 1B that proved impossible to sequence by
conventional methods and therefore was sequenced by MS as
described elsewhere [25]. All intron–exon boundaries were
sequenced. Most intron sequences were also determined. The ob-
tained sequences were analysed and assembled by programs
from the GCG package (Genetics Computer Group, Madison,
WI, U.S.A.). Genomic Southern blotting was performed by
standard procedures using as a probe a 386 bp fragment gener-
ated by PCR on a genomic clone containing the 3«-end of the
gene with the primers 5«-CAGAGAGCAAGTGGGCAG-3« and
5«-AGGTGTGCCAGCATCTCCC-3«.
Primer extension
RNA (10 lg) in annealing buffer (250 mM KCl}10 mM
Tris}HCl, pH 8.3, at 42 °C) was annealed with 0.5 pmol of
$#P-labelled primer [exon 1A, 5«-AGGGCTCAGGAGCGGC-
TTC-3« (50 °C); exon 1B, 5«-TTCCCATTAATCCCCAGG-
TC-3« (45 °C); exon 1C, 5«-GAATCCAACATTGAAGGCCC-
A-3« (50 °C); exon 1D, 5«-CAGTCCTGTCTCCAGATCTG-3«
(50 °C)] for 1 h at the temperature indicated, followed by the
addition of 14 ll of extension mixture [66 mM Tris}HCl, pH 8.3,
at 42 °C, 4 mM MgCl
#
, 13.3 mM dithiothreitol, 0.66 mM dNTP,
14.3 units}llMoloney-murine-leukaemiavirus (M-MLV) reverse
transcriptase (Gibco BRL) and 133 lg}ml actinomycin D] and
extension for 1 h. The reaction was terminated by addition of
EDTA to 10 mM, and the samples were dried, redissolved in
formamide dye mix and run on a denaturing gel. Sets of corre-
sponding sequencing reactions using the same primers were run
alongside the samples as markers.
5«-Rapid amplification of cDNA ends (RACE)
Two first-strand synthesis reactions were set up as outlined in
the Capfinder kit (Clontech) protocol using 1 lg of liver RNA
isolated from aC57Bl}6J mouse and theCDS}3« primer provided
in the kit, or a gene-specific primer (5«-TCTCCTCCTGTG-
GCTGTTCCATGACTGACC-3«). The first-strand product
was used as a template in a PCR with the 5«-PCR primer pro-
vided in the kit and the gene-specific primer using Pfu DNA
polymerase. The product was purified on a High-pure column
(Roche) and reamplified using the 5«-PCR primer provided in
the kit and a nested gene-specific primer, (5«-CCTGCAGGCC-
TGGTCATAGC-3«). The resulting products were cloned into
pBluescript KS› and analysed by sequencing.
Cell culture
3T3-L1 preadipocytes were grown to confluence and induced to
differentiate as described in [26]. Briefly, preadipocytes were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% calf serum and, 2 days after reaching confluence
(day 0), differentiation was induced by culturing the cells in
DMEM with 10% fetal calf serum, 167 nM insulin, 0.5 mM
methylisobutylxanthine and 0.25 lM dexamethasone for 2
days, DMEM with fetal calf serum and insulin for 2 days and
DMEM with fetal calf serum until RNA was isolated.
3T3-F442A preadipocytes were grown to confluence and in-
duced to differentiate to adipocytes as described previously [23].
Briefly, preadipocytes were cultured in DMEM supplemented
with 10% fetal bovine serum (termed standard medium) and
after reaching confluence (day 0), differentiation was induced by
culturing cells in the same medium containing 17 nM insulin and
2 nM tri-iodothyronine (termed differentiation medium). Media
were changed every other day. HEK-293 cells were maintained
in standard medium.
Transient transfections
The following promoter fragments were cloned into pGL3 Basic
(positions relative to the A in the AUG start codon in the spliced
mRNA): 1A, approx. fi4000 to fi72 in the 1A promoter ;
1B3}4, fi393 to fi172 in the 1B promoter ; 1B1-4, fi1089 to
fi256 in the 1B promoter ; 1C, fi2786 to fi188 in the 1C pro-
moter ; 1D, approx. fi2400 to fi85 in the 1D promoter. The
promoter activity was evaluated by performing transfections
with the FuGENE 6 transfection reagent (Roche Molecular
Biochemicals) according to the manufacturer’s instructions.
Typically, for four wells of a 24-multiwell culture plate, 2 lg of
luciferase construct was co-transfected with 50 ng of pCMV-b-
galactosidase, a control vector used to monitor transfection
efficiency. Luciferase construct used in this range of concentra-
tions leads to saturating conditions where the result is largely
independent of the DNA concentrations in the range used here
(results not shown). DNA in 100 ll of DMEM was complexed
with 3 ll of FuGENE 6 for 15 min before addition of 2 ml of
either standard or differentiation medium. The cells were incu-
bated in the presence of the transfection mixture (0.5 ml}well)
for 6–8 h, and were then maintained in standard or differentiation
media for a further 36 h before lysis for reporter assays.
Luciferase and b-galactosidase activities were determined in
the same cell extract using a Berthold luminometer and com-
mercial kits. Luciferase activities were determined in quad-
ruplicate and normalized to b-galactosidase activities. The
experiment was performed three times.
RNA isolation and Northern analysis
Total RNA was isolated from the cultured cells at various time
points during the differentiation process or from tissues isolated
from male C57 black mice and subjected to Northern analysis.
Filters were stained with Methylene Blue to confirm equal
loading and hybridized to DNA probes labelled with $#P by
random primer extension.
Western blotting
Western blotting was performed as described in [27]. PPARb}d
antiserum was obtained from Walter Wahli (Institut de Biologie
Animale, Universite de Lausanne, Lausanne, Switzerland). The
bands containing PPARb}d were identified by co-migration
with PPARb}d obtained from NIH-3T3 cells transfected with
a construct encoding full-length PPARb}d.
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Figure 1 Structure of the mouse PPARb/d gene
(A) The splicing patterns used for generating mRNA initiated from the four different promoters. Exon 1A is spliced to exon 3 ; exon 1B is spliced to exon 2 which is spliced to exon 3 ; exon 1C
is spliced to exon 2 which is spliced to exon 3 ; exon 1D is spliced to exon 3. (B) The 1B promoter harbours a CpG island. The most upstream transcription start point of the 1B promoter is
situated at position 4940. Grey, CpG content ; black, observed/expected occurrences of CpG. (C) Genomic Southern blot demonstrating the absence of PPARb/d pseudogenes.
Coupled in vitro transcription/translation and reverse
transcriptase PCR
Coupled in itro transcription and translation was performed
with a TNT kit (Promega) as described by the manufacturer,
using equimolar amounts of the following linearized templates
which all contained the full-length coding region of the PPARb}d
mRNA; fi134 (C 1A) containing the 1A 5«-untranslated region
(UTR) from position fi134; fi548 (C 1B1) containing the
1B1 5«-UTR from position fi548; fi284 (C 1B4) containing
the 1B 5«-UTR from position fi284; fi236 (C 1C) contain-
ing the 1C 5«-UTR from position fi236; fi166 (C 1D)
containing the 1D 5«-UTR from position fi166; and fi31
(C exon 3) containing exon 3-originating 5«-UTR from position
fi31. All constructs were cloned into pBluescript KS›. The
products of the coupled transcription}translation were run on
SDS}PAGE gels (10%) in a Tris}tricine system with a resolving
capacity down to approx. 2000 Da.
RNA was prepared from 20 ll of TNT product in Tris}tricine
sample buffer by adding 200 ll of Gd-SCN buffer [4 M guani-
dine thiocyanate, 0.1% antifoam A (Sigma), 25 mM sodium
citrate, 100 mM b-mercaptoethanol, 0.5% sodium N-lauroyl
sarcosine, pH 7.0] and 10 ll of 2 M sodium acetate, pH 4.0.
After vigorous vortexing, the RNA was extracted with 100 ll of
phenol and 20 ll of chloroform. The aqueous phase was isolated,
the RNA prepared with RNAtack resin (Biotecx) as described
by the manufacturer and eluted in 40 ll of water. Isolated RNA
(5 ll) was subjected to digestion with 5 units of RNase-free
DNase I (Boehringer) in 1 mM MgCl
#
and reverse transcription
was performed on 1.5 ll of RNA by M-MLV reverse tran-
scriptase using the PPARb}d-specific primer 5«-TTCTAGA-
GCCCGCAGAATGG-3«. PCR was performed (20 and 25
cycles) with the primers 5«-GGCCATGGGTGACGGAGC-3«
and 5«-GATCTTGCAGATCCGATCGC-3« and the products
run on an agarose gel.
RESULTS AND DISCUSSION
The structure of the gene encoding murine PPARb/d
To isolate the murine PPARb}d gene, a k genomic library was
screened with a probe containing the entire open reading frame
of the mouse mRNA encoding PPARb}d [23,24]. Two different
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Table 1 Sequences of the intron/exon boundaries of the mouse gene
encoding PPARb/d
The non-coding exon 1A is spliced to exon 3, the non-coding exons 1B and 1C are spliced
to the non-coding exon 2 and the non-coding exon 1D is spliced to exon 3. Nucleotides in exons
are indicated in upper case whereas the flanking nucleotides are in lower case. Numbers shown
in parentheses are the exon sizes. Intron sizes are also given.
Exon
Intron
ExonDonor Size Acceptor
1a (68 bp) CCCTGgtgagtagag 25.6 kb ccctgcccagGCAGT 3
1b (384 bp) GACAGgtccgtgcgg 4.1 kb caccttacagTGCTG 2
1c (72 bp) TTCAGgcatgtgggt 380 bp caccttacagTGCTG 2
2 (84 bp) TAAAGgtaagcccgc 10.2 kb ccctgcccagGCAGT 3
1d (47 bp) CTGAGgtaagcaggg 6.5 kb ccctgcccagGCAGT 3
3 (207 bp) TGCAGgtatggaggg 8.8 kb gtcttcacagACCTC 4
4 (155 bp) GCAAGgtacagatgg 1592 bp ggtctcgcagGGCTT 5
5 (139 bp) CAACGgtgagggcgc 1053 bp ccctatgcagCTATC 6
6 (203 bp) ACGCAgtgagtgtca 105 bp tggttttcagCCCTT 7
7 (451 bp) TGGAGgtgagggggc 568 bp gtccccacagACCGG 8
8 (1867 bp)
Figure 2 Determination of transcription initiation sites of the mouse PPARb/d 1A, 1B, 1C and 1D promoters
Primer extensions were performed using primers specific for exons 1A, 1B, 1C and 1D. Numbering is relative to the AUG start codon in the spliced mRNAs. Size standards were prepared by
thermo-sequencing plasmid templates using the same primers. WAT, white adipose tissue.
clones were isolated and sequenced partially. The sequencing and
comparison with rat [28] and human [22] PPARb}d sequences
revealed the presence of additional exons in the 5«-end of the
PPARb}d gene. Therefore, a mouse P1 bacteriophage library
was screened with the intron-specific primers 5«-CCTGCAG-
GCCTGGTCATAGC-3« and 5«-GGACAGCTGCGTCCTGA-
G-3«. Three clones were obtained and tested for upstream exon(s)
by PCR with the rat-specific primers 5«-GGATTCTGCGG-
AGCGTGCG-3«and5«-CTGTCAGTGAGCAGGAGCCTC-3«.
One P1 clone was found positive and was selected for further
characterization. In parallel, 5«-RACE was performed on RNA
from mouse liver using primers specific for part of the coding
sequence (exon 3) to identify the first exon(s) of the gene. The
products were cloned and the 5«-ends analysed by sequencing.
Unexpectedly, a number of differentially spliced products were
found, the most prevalent of which included or were initiated in
exon 1B (Figure 1 and results not shown).
A library of subclones was generated from the P1 clone
by cloning partially Sau3AI-digested P1 DNA into pBlue-
script KS›. Screening with specific oligonucleotides identified
subclones harbouring exons 1B, 1C and 2. Subclones harbouring
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Figure 3 Promoter activity of the 1A, 1B, 1C and 1D promoters
The activities of the PPARb/d promoters in HEK-293 cells, 3T3-F442A preadipocytes and 3T3-
F442A adipocytes (day 6) were determined after transient transfection with various PPARb/d
promoter fragments harbouring E 4 kb (1A), 222 bp (1B3/4), 834 bp (1B1-4), 2599 (1C) and
E 2.5 kb (1D) of the promoter regions cloned into pGL3 Basic. Promoter activity was
determined relative to b-galactosidase activity as described, and normalized to the activity of
pGL3 Basic. Results are shown as the means‡S.E.M. from three experiments.
exons 1A and 1D were generated by long-range PCR using
primers designed from the cDNA sequences.
Thus the gene encoding PPARb}d spans approx. 41 kb
(Table 1 and Figure 1A) and, in analogy with the genes
encoding PPARa [21] and PPARc [20,29], it comprises six
exons in the 3«-end common to all transcripts. Tissue-dependent
promoter usage (see below) and differential splicing yielded a
variety of transcripts comprising one or two of the five exons
present in the 5«-end of the mouse PPARb}d gene spliced to the
common six exons located in the 3«-end of the gene. However, in
contrast to PPARc, neither of the mRNAs have the potential
to encode variant PPARb}d isoforms. Interestingly, exon 2 is
skipped when the first exon of the primary transcript is exon 1A.
The most abundant mRNA has a predicted length of 3490 nt and
exhibits high homology with the published sequence of the rat
messenger [28], but contains only three CGG triplet repeats
instead of the 14 repeats noted there. The human PPARb}d gene
[22] had its transcription start point mapped to an exon with high
homology to mouse exon 1B, contains no CGG triplet repeat
and contains one additional non-coding exon placed between
exons 1B and 2.
The splice donor}acceptors of the mouse PPARb}d gene
conform to the splice consensus sequence GT}AG except the
splice donor of exon 1C (Table 1). The homology between
the 3«-UTRs of human and mouse PPARb}d is not high except
for the last 159 nt, where a stretch of nucleotides exhibits
91% identity and a conserved AATAAA polyadenylation signal
is present.
Unlike the other PPARs, PPARb}d is ubiquitously expressed
and is expressed early in embryonic development [24,30–32].
Exon 1B of the murine as well as exon 1 of the human gene [22]
contain CpG islands [33] (Figure 1B and results not shown), a
trait often associated with this family of housekeeping genes.
Based on their expression in the germ line, most housekeeping
genes have pseudogenes, but this is not the case for the murine
PPARb}d gene (Figure 1C).
Determination of transcription start sites
Transcription start sites in the different promoters were de-
termined by primer extension using primers complementary
to sequences in the first exons (Figure 2). The transcription-
initiation sites of exons 1A and 1C are situated 138 and 280 nt
upstream of the AUG translational start codon in the processed
mRNA, respectively ; exon 1B has several transcription start
sites although the site (1B1) situated at position fi548 is preferred
in all tissues examined. Exon 1D has a major initiation site at
position fi127, but also minor sites at positions fi129, fi298
and fi329 (results not shown). Initiation site usage is differen-
tially regulated, also within one promoter. One example is liver,
where transcripts originating from transcription start point
1B2 are under-represented relative to those originating from
transcription start points 1B1, 1B3 and 1B4 in other tissues
(Figure 2). These results also corroborate the notion that mul-
tiple initiation sites are present in the 1B promoter and that the
multiple bands observed by primer-extension analysis do not
represent artifacts.
Analysis of promoter activity
The relative strength of the different promoters was compared
by transient transfection in HEK-293 and 3T3-F442A cells
using promoter constructs containing approx. 4 kb (1A), 2.6 kb
(1C) or 2 kb (1D) of promoter sequences (Figure 3). A number
of promoter constructs containing various fragments of the 1B
promoter were also tested (Figures 3 and 1A). Whereas the
1B promoter (1B1-4, position fi1089 to fi256) seems to be
the strongest in HEK-293 and 3T3-F442A preadipocytes, the 1C
promoter seems to be more potent in 3T3-F442A adipocytes.
Surprisingly, a minimal promoter containing only the 1B3 and
1B4 transcription-initiation sites (position fi393 to fi172)
proved to have a very strong activity in all the cell types tested.
This could indicate the presence of an element conferring
transcriptional repression upstream of the 1B3 initiation sites
or, alternatively, the presence of an element enhancing tran-
scription between position fi256 and fi172, or a combination
of both. Interestingly, the transcriptional repression or lack of
activity of the possible positively acting downstream element is
so pronounced in the differentiated adipocytes that the tran-
scriptional activity of the 1B1-4 promoter is as low as that of
the pGL3 vector without any inserted promoter elements in this
cell type.
A search of the involved regions using the Matinspector
program [34] revealed that a negative element between the 1B1
and 1B3 initiation sites could be a site binding the ubiquitously
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Figure 4 The 5«-ends of the processed PPARb/d mRNAs harbour good Kozak consensus sequences and long open reading frames
Shown is a schematic representation of transcripts initiated from the various PPARb/d promoters where the sizes of the leaders, the presence of AUG triplets and the sizes of possible open reading
frames are indicated. AUG codons are marked by asterisks and AUG codons in good agreement with the Kozak consensus sequence are marked with boxed asterisks. Open reading frames larger
than 60 nucleotides are shown as cross-hatched bars and the sizes of their predicted products indicated.
expressed bZip transcription factor TCF11 [35], which is able to
repress transcription when bound to small musculoaponeurotic
fibrosarcoma oncogene family (Maf) proteins, whereas two sites
in the downstream promoter present only in the 1B3}1B4
construct could bind the ubiquitously expressed transcription
factor activator protein 4 [36,37]. A more thorough promoter
analysis will be necessary to fully characterize the promoters of
the murine PPARb}d gene.
The activity of the 1C promoter is quite high in adipocytes in
itro whereas the 1C promoter seems to be only modestly used
in io in fat (Figure 2). White adipose tissue consists of a
number of cell types of which many are more transcriptionally
active than the adipocytes. Thus the proportion of transcripts
from the 1C promoter might be decreased in RNA isolated from
adipose tissue due to the contribution of transcripts from cells
other than adipocytes. Alternatively, the promoters used in the
transfection assays may not include all elements used in io or
the cell lines used may not reflect the in io situation when
comparing the activities of the different promoters.
The data obtained from the 5«-RACE where the majority of
clones obtained were 1B-derived indicated that the 1B promoter
is predominantly used in io in the liver. Several lines of
evidence indicate that 1B transcripts are the most abundant in a
number of tissues, if not all. These data also include the primer
extensions where the 1B primer extensions consistently yielded
the strongest bands in a number of experiments (see Figure 2).
Furthermore, only the 1B homologue was found in the studies
concerning the human PPARb}d gene structure [22] and the rat
PPARb}d cDNA [28].
Analysis of translational efficiency
An analysis of the 5«-UTRs resulting from transcription initiated
from the different promoters revealed that especially the tran-
script initiated from the most upstream (major) 1B promoter
contains a number of Kozak-compatible AUG codons [38]
with associated open reading frames (Figure 4), whereas the
shorter transcripts originating from the 1A, 1C and 1D pro-
moters contain only a single Kozak-compatible AUG start
codon. In vertebrates, translation is normally initiated from
the first AUG codon with a strong Kozak consensus sequence
whereas downstream AUG codons are not used.
Coupled transcription and translation in a rabbit reticulocyte
system yielded markedly less product from a template transcribed
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into the full-length 1B message [Figure 5, fi548 (C 1B1)] than
transcripts generated from templates encoding 1A, 1C or 1D
messages. Coupled transcription}translation of a template
encoding an mRNA containing no upstream AUG codons
[Figure 5, fi31 (CExon 3)] gave rise to a significantly higher
level of the translation product in comparison with the yield
obtained from any of the exon 1A-, 1B-, 1C- or 1D-containing
transcripts, emphasizing the role of the 5«-UTRs in attenuating
translational efficiency.
We were unable to detect any products originating from
alternative translation start points in the 1A, 1B, 1C or 1D mess-
ages in the rabbit reticulocyte lysate, as well as in a wheatgerm
TNT system (results not shown), indicating that the upstream
open reading frames are not translated or are only translated with
very low efficiency, at least in the in itro systems. Alternatively,
any produced polypeptides may turn over very rapidly.
Figure 5 The 1B 5«-UTR inhibits translation
TNT, coupled in vitro transcription and translation with templates harbouring different UTRs
from the gene encoding PPARb/d. RT-PCR, the amounts of transcripts were semi-quantitatively
assessed by reverse transcriptase PCR. Various cycle numbers were tested and a representa-
tive gel is shown where the reactions were not saturated. The numberings correspond to the
5«-most position of the UTR relative to the A in the AUG start codon.
Figure 6 Tissue- and differentiation-specific expression of PPARb/d and
PPARc at the mRNA level
Northern blots were prepared using RNA from differentiating 3T3-L1 cells and from a number
of mouse tissues. The results from probing with PPARb/d and PPARc are shown. Equal
loading/transfer was determined by Methylene Blue staining of rRNA on the blots. Numbers
on the left indicate days in the differentiation process, where day fi2 is the day of confluence
of the cells.
Figure 7 Tissue- and differentiation-specific expression of murine PPARb/d at the protein level
Protein was extracted from differentiating 3T3-L1 cells (left-hand panel) and from a number of mouse tissues (right-hand panel). They were subjected to Western blotting using a TATA-box-
binding-protein-specific antibody (TBP) for normalization or a PPARb/d-specific antibody. The identity of the PPARb/d band was confirmed by its co-migration with PPARb/d obtained from
PPARb/d-transfected NIH-3T3 cells. WAT, white adipose tissue. Numbers on the left indicate days in the differentiation process.
Northern analysis (Figure 6) confirmed previous findings
that PPARc exhibits quite a tissue-restricted pattern of ex-
pression, whereas PPARb}d is ubiquitously expressed with the
highest levels of expression in intestine, colon and appendix
and only minute amounts of mRNA present in kidney and
testis. Furthermore, expression of PPARb}d has been noted to
be strongly induced during the differentiation of Ob1771 and
3T3-F442A preadipocytes [23], and is also induced, albeit to a
lesser degree, in 3T3-L1 adipocyte differentiation (Figure 6).
Interestingly, expression of the PPARb}d protein (Figure 7)
does not correlate with the mRNA levels (Figure 6). Thus there
is a lack of induction of the PPARb}d protein during 3T3-L1
adipocyte differentiation (Figure 7, bottom row), and the ex-
pression of PPARb}d protein seems to be much lower in the
colon and intestine than in a number of tissues (e.g. liver) where
the mRNA levels are much lower. Taken together, these results
suggest a marked regulation of PPARb}d at the level of alterna-
tive promoter usage and initiation of translation.
The regulation of translation by the usage of alternative pro-
moters and}or alternative splicing and inhibition of translation
by long 5«-UTRs containing AUG codons has been noted, es-
pecially for a number of genes encoding transcription factors and
other regulatory proteins [39–42]. Thus the gene encoding the
runt domain transcription factor AML1}RUNX1 is transcribed
from two promoters ; the UTR originating from transcription
initiated at the proximal promoter contains two CpG islands
able to form a stable stem-loop structure and 16 AUG codons.
Translation of this mRNA is initiated through an IRES-mediated
mechanism and is regulated in a cell- and differentiation-specific
manner, whereas the mRNA initiated from the distal promoter
is shorter, contains no GC-rich stretch and has translation
initiated by a cap-dependent mechanism [40].
Since the structure of the gene encoding PPARb}d resembles
the structure of the gene encoding AML1}RUNX1, we per-
formed a series of experiments to investigate if the 5«-UTR of
the 1B1-initiated transcript could mediate internal ribosome
entry. A bicistronic construct was prepared and tested by
transfection into NIH-3T3 fibroblasts. As expected, we found
activity from both reporter genes, but an equivalent promoterless
construct prepared as a control for internal promoter activity
showed the same amount of downstream reporter gene ac-
tivity, indicating that the activity of the second cistron in the first
experiment was not necessarily the result of internal ribosome
entry, but might also be due to transcriptional initiation directed
by a promoter activity harboured in the 5«-UTR (results not
shown and Figure 3).
A number of viral as well as cellular genes have, in
analogy with the AML1}RUNX1 gene, been shown to be
translationally initiated via an IRES-dependent mechanism. The
cellular genes include the genes encoding platelet-derived growth
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factor 2}c-sis [43], fibroblast growth factor 2 [44], a cardiac
voltage-gated potassium channel [45], the max-binding protein
(mnt) transcriptional repressor [46], c-Myc [47,48], apoptotic
protease-activating factor (Apaf-1) [49,50], cationic amino acid
transporter 1 (cat-1) [51], immunoglobulin heavy-chain-binding
protein (BiP) [52], vascular endothelial growth factor [53], MYT2
[54], insulin-like growth factor II [55] and insulin-like growth
factor I receptor [56]. In a number of cases where the evidence
for a functioning IRES was obtained by transfecting bicistronic
constructs into cells, the authors may have misinterpreted
transcriptional activity or cryptic splice sites within the 5«-UTR
(or postulated IRES). These events could lead to transcripts
containing just the second cistron [57], which would then be
translatable without internal ribosome entry.
In the PPARb}d transcripts initiated at the 1B1 promoter, the
energetically most favourable folded secondary structure has a
free energy of folding of fi207.5 kcal}mol and will therefore
pose a very difficult structure for a ribosome to traverse. It has
been shown that initiation of translation of mRNAs with
secondary structures of standard free energy values of folding up
to approx. fi30 kcal}mol is easily accomplished by the scanning
mechanism, whereas the scanning 43 S preinitiation complex is
stalled by more stable structures [58] and thus it seems unlikely
that the translation of the longest PPARb}d transcript is initiated
by the scanning mechanism, suggesting that the ribosomes enter
the transcript internally. However, due to the presence of a
cryptic promoter in the 5«-UTR further investigations are needed
to determine if the translation of the most abundant PPARb}d
transcript is accomplished by internal ribosome entry, by
ribosome shunting or simply by the scanning mechanism.
An article describing the structure of the mouse PPARb}d
gene [59] was published during the review process of the present
article. This article describes the basic structure of the PPARb}d
gene but only reports on the presence of eight exons (exons 1B
and exons 2–8 in the present article) and hence the article does
not describe the complexity of the promoter structure and the
post-transcriptional regulation of the gene encoding PPARb}d.
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